−0.005CAD
−331.97 KCAD
13.29 MCAD
44.52 M
About NEXGENRX INC.
Sector
CEO
Ronald Campbell Loucks
Website
Headquarters
Toronto
Founded
2003
ISIN
CA65337X1042
FIGI
BBG0086KD0M2
NexgenRx, Inc. engages in the provision of administrative services only (ASO) (Self-Funded) drug, dental and extended health benefit plans supported by technology. It offers prescription drug claims; dental claims; and claims for extended health benefits, as well as provides a health care spending account that offers an amount of money to an individual to pay for health or dental benefits. The company was founded by Ronald Campbell Loucks on March 13, 2003 and is headquartered in Toronto, Canada.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of NXG is 0.235 CAD — it has decreased by 12.96% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NEO exchange NEXGENRX INC. stocks are traded under the ticker NXG.
NXG stock is 14.89% volatile and has beta coefficient of 0.80. Check out the list of the most volatile stocks — is NEXGENRX INC. there?
Yes, you can track NEXGENRX INC. financials in yearly and quarterly reports right on TradingView.
NXG net income for the last quarter is −387.58 K CAD, while the quarter before that showed −130.73 K CAD of net income which accounts for −196.47% change. Track more NEXGENRX INC. financial stats to get the full picture.
Like other stocks, NXG shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade NEXGENRX INC. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So NEXGENRX INC. technincal analysis shows the strong sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating NEXGENRX INC. stock shows the strong sell signal. See more of NEXGENRX INC. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. NEXGENRX INC. EBITDA is 604.61 K CAD, and current EBITDA margin is 4.55%. See more stats in NEXGENRX INC. financial statements.